Most importantly, via the evaluation of NEDD4 expression in a subset of DCIS, IDC, and BC cases with lymph node metastasis (BCLNM) tumors, a gradually increased proportion of NEDD4 staining was observed to the advantage of BC. The gene discussed is NEDD4; the disease is metastatic malignant neoplasm in the lymph nodes.